HR 6977 · 118th Congress · Health

Independent Drug Value Assessment Act of 2024

Introduced 2024-01-11· Sponsored by Rep. Nadler, Jerrold [D-NY-12]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2024-01-12)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 6977 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 6977 To amend the Public Health Service Act to provide for a demonstration project for the development and publication of independent value assessments for drugs, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES January 11, 2024 Mr. Nadler (for himself and Ms. Porter) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Public Health Service Act to provide for a demonstration project for the development and publication of independent value assessments for drugs, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Independent Drug Value Assessment Act of 2024''. SEC. 2. DEMONSTRATION PROJECT FOR INDEPENDENT VALUE ASSESSMENTS FOR DRUGS. Part D of title III of the Public Health Servic…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (2)

2 Democrats